Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia-Reference-Cited by-同舟云学术

Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia

Published:2007-02-01 Issue:3 Volume:21 Page:556-560
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Yoshimi A, ,Mohamed M,Bierings M,Urban C,Korthof E,Zecca M,Sykora K-W,Duffner U,Trebo M,Matthes-Martin S,Sedlacek P,Klingebiel T,Lang P,Führer M,Claviez A,Wössmann W,Pession A,Arvidson J,O'Marcaigh A S,van den Heuvel-Eibrink M M,Starý J,Hasle H,Nöllke P,Locatelli F,Niemeyer C M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2404537.pdf

Reference8 articles.

1. Locatelli F, Nollke P, Zecca M, Korthof E, Lanino E, Peters C et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 2005; 105: 410–419.

2. Yoshimi A, Bader P, Matthes-Martin S, Stary J, Sedlacek P, Duffner U et al. Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. Leukemia 2005; 19: 971–977.

3. Bosi A, Laszlo D, Labopin M, Reffeirs J, Michallet M, Gluckman E et al. Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol 2001; 19: 3675–3684.

4. Manabe A, Okamura J, Yumura-Yagi K, Akiyama Y, Sako M, Uchiyama H et al. Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML working group. Leukemia 2002; 16: 645–649.

5. Yusuf U, Frangoul HA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG et al. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience. Bone Marrow Transpl 2004; 33: 805–814.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric Myeloproliferative Disorders/Myelodysplastic Syndromes/Overlap Syndromes;Tata Memorial Centre Textbook of Oncology;2024

2. Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation;Clinical Case Reports;2023-11

3. Azacitidine (Vidaza®) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015);Pediatric Drugs;2023-09-11

4. Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft;Bone Marrow Transplantation;2023-02-23

5. Mixed chimerism post haematopoietic stem cell transplantation in JMML : Interventions and outcome;British Journal of Haematology;2022-09-25